13G Filing: Woodford Investment Management and Northwest Biotherapeutics Inc (NWBO)

SCHEDULE 13G

CUSIP NO. 66737P600

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

The Manager is an investment manager and the funds
managed by it have the right to receive and the power to direct the receipt of dividends or the profits from the sale of such securities.
The Woodford Fund beneficially owns more than 5% of the of the issued and outstanding Common Stock of the Issuer (see Item 4).

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

See Exhibit 1.

Item 9.

Notice of Dissolution of a Group.

Not applicable.

Item 10.

Certification.

By signing below each member
of the Group certifies that, to the best of his or its knowledge and belief, (i) the securities referred to above were acquired
and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose or effect and (ii) the foreign regulatory scheme applicable to investment
managers authorized and regulated by the Financial Conduct Authority of the United Kingdom is substantially comparable to the
regulatory scheme applicable to the functionally equivalent U.S. institution(s). Each member of the Group also undertakes to furnish
to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.